Clinical Trial Update: Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544 [Phase 2]

View source ↗

Summary

Phase 2 proof-of-principle trial in semi-immune adults in Burkina Faso evaluated the efficacy of methylene blue for treating malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Heidelberg University | Conditions: Malaria | Phase 2 | Status: COMPLETED